Show simple item record

dc.contributor.authorZwakenberg, Sabine R
dc.contributor.authorvan der Schouw, Yvonne T
dc.contributor.authorSchalkwijk, Casper G
dc.contributor.authorSpijkerman, Annemieke M W
dc.contributor.authorBeulens, Joline W J
dc.date.accessioned2018-04-19T11:13:02Z
dc.date.available2018-04-19T11:13:02Z
dc.date.issued2018-03-23
dc.identifier.citationBone markers and cardiovascular risk in type 2 diabetes patients. 2018, 17 (1):45 Cardiovasc Diabetolen
dc.identifier.issn1475-2840
dc.identifier.pmid29571288
dc.identifier.doi10.1186/s12933-018-0691-2
dc.identifier.urihttp://hdl.handle.net/10029/621821
dc.description.abstractVascular calcifications are associated with a three- to fourfold increased risk of cardiovascular disease (CVD) and are highly prevalent in type 2 diabetes patients. Emerging evidence indicates that vascular calcification is a process of active bone formation regulated by stimulators and inhibitors of calcification. Therefore, this study aimed to evaluate whether six bone markers are associated with CVD risk in patients with type 2 diabetes.
dc.language.isoenen
dc.rightsArchived with thanks to Cardiovascular diabetologyen
dc.titleBone markers and cardiovascular risk in type 2 diabetes patients.en
dc.typeArticleen
dc.identifier.journalCardiovasc Diabetol 2018; 17(1):45en
html.description.abstractVascular calcifications are associated with a three- to fourfold increased risk of cardiovascular disease (CVD) and are highly prevalent in type 2 diabetes patients. Emerging evidence indicates that vascular calcification is a process of active bone formation regulated by stimulators and inhibitors of calcification. Therefore, this study aimed to evaluate whether six bone markers are associated with CVD risk in patients with type 2 diabetes.


This item appears in the following Collection(s)

Show simple item record